title: Acceptability of fingerstick versus oral fluid rapid HIV testing: results from the universal screening for HIV infection in the emergency room (USHER Phase II) randomized controlled trial.
abstract: BACKGROUND
  Oral rapid HIV testing has been reported to have a lower sensitivity and specificity than rapid HIV testing with whole blood and has been associated with clusters of false-positive results. Patient preference for oral rapid HIV testing compared with more invasive whole blood fingerstick may influence the acceptance of rapid HIV testing.
  
  
  OBJECTIVE
  To compare HIV test acceptance rates among patients routinely offered fingerstick compared with those routinely offered oral fluid screening in an urban hospital emergency department.
  
  
  METHODS
  The Universal Screening for HIV Infection in the Emergency Room Phase II was a single-center, prospective, randomized controlled trial that randomized subjects to either fingerstick or oral rapid HIV screening in an urban academic emergency department. From May 5, 2009, to January 4, 2010, eligible patients aged 18-75 years were invited to participate in the trial. The primary outcome measure was HIV test acceptance rate.
  
  
  RESULTS
  : 2012 eligible patients were approached, of whom 1651 (82%) consented to trial participation and enrolled. Among those enrolled, 830 and 821 were randomized to the fingerstick and oral fluid arms, respectively. Acceptance of rapid HIV testing was similar in both arms; 67% (553 of 830) of subjects accepted fingerstick testing compared with 69% (565 of 821) who accepted oral (P = 0.34).
  
  
  CONCLUSIONS
  Although fingerstick rapid HIV testing is more invasive than oral fluid testing, test acceptance rates did not differ. Given the option, preference should therefore be given to fingerstick testing because of its slightly superior test characteristics. System factors such as ease of staff use, necessary Clinical Laboratory Improvement Amendments waivers, laboratory capacity, and HIV prevalence should also be considered.
authors.affiliation: Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. ldonnell-fink@partners.org
authors.forename: Laurel A
authors.initials: LA
authors.lastname: Donnell-Fink
authors.forename: Christian
authors.initials: C
authors.lastname: Arbelaez
authors.forename: Jamie E
authors.initials: JE
authors.lastname: Collins
authors.forename: Anna
authors.initials: A
authors.lastname: Novais
authors.forename: Amy
authors.initials: A
authors.lastname: Case
authors.forename: Mary L
authors.initials: ML
authors.lastname: Pisculli
authors.forename: William M
authors.initials: WM
authors.lastname: Reichmann
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Katz
authors.forename: Elena
authors.initials: E
authors.lastname: Losina
authors.forename: Rochelle P
authors.initials: RP
authors.lastname: Walensky
mesh_terms: D015492:AIDS Serodiagnosis / Q000379:methods*; D000328:Adult; D004632:Emergency Medical Services; D005260:Female; D015483:HIV Antibodies / Q000032:analysis / Q000097:blood; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D057240:Patient Preference; D011446:Prospective Studies; D012463:Saliva / Q000276:immunology
chemical_list: D015483:HIV Antibodies